The chemical class associated with SLC26A6 encompasses diverse compounds, mostly inhibitors or activators of various intracellular signaling pathways. These chemicals are not direct activators of SLC26A6; instead, they influence the protein's activity through their action on various signaling molecules within the cell. For instance, agents like forskolin, 8-Bromo-cAMP, and IBMX operate through the modulation of cAMP levels, a second messenger crucial for the regulation of a variety of proteins, including ion transporters like SLC26A6. These compounds can foster an environment conducive to the protein's enhanced activity, be it through its increased expression, altered phosphorylation state, or changed interaction with other cellular constituents.
Other chemicals in this class, such as U0126, SB202190, and SP600125, target MAP kinase pathways, crucial conduits for the transduction of extracellular signals to the cellular machinery. These inhibitors can affect the phosphorylation status of various substrates downstream in the signaling cascade, including potentially those directly or indirectly associated with SLC26A6. Similarly, compounds like Rapamycin and LY294002 are involved in the regulation of cellular growth and survival pathways through mTOR and PI3K, respectively. By influencing these pathways, these chemicals can affect the broader cellular environment in which SLC26A6 functions, thereby impacting its activity, albeit indirectly. These diverse regulatory pathways underscore the intricate cellular network within which SLC26A6 operates, and the compounds that modulate these pathways provide valuable tools for dissecting the functional nuances of this transporter.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Stimulates adenylate cyclase, increasing intracellular cAMP levels, which can enhance SLC26A6's activity by promoting its translocation or expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that can regulate various cellular processes, potentially influencing the phosphorylation state of proteins related to SLC26A6 function. | ||||||
8-Bromoguanosine 3′, 5′ -cyclic monophosphoric acid | 31356-94-2 | sc-291685 sc-291685A | 5 mg 10 mg | $116.00 $206.00 | ||
A cAMP analog that can permeate cell membranes and elevate intracellular cAMP, thus possibly enhancing the activity or expression of SLC26A6. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A phosphodiesterase inhibitor, raises cAMP levels, which can indirectly promote the activity of SLC26A6 by affecting its expression or membrane localization. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
A p38 MAPK inhibitor that can affect cellular stress responses, potentially influencing the regulation of SLC26A6 under these conditions. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, which can influence energy balance and possibly the regulation of SLC26A6 in terms of its expression or activity during metabolic stress. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
An inhibitor of Ras farnesyltransferase, can affect Ras-mediated signaling pathways, potentially impacting the regulation or expression of SLC26A6. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can influence cell growth and survival pathways, potentially affecting the activity or stability of SLC26A6 in these pathways. | ||||||